BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 20059332)

  • 1. Heparin-induced thrombocytopenia.
    Arepally GM; Ortel TL
    Annu Rev Med; 2010; 61():77-90. PubMed ID: 20059332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia.
    Lee GM; Arepally GM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():668-74. PubMed ID: 24319250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: research and clinical updates.
    Onwuemene O; Arepally GM
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):262-268. PubMed ID: 27913490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
    Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
    Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia.
    Chong BH; Chong JJ
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):547-59. PubMed ID: 15225114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
    Chang JJ; Parikh CR
    Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
    Deitcher SR; Carman TL
    Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia: diagnostic tests and biological mechanisms.
    Amiral J; Meyer D
    Baillieres Clin Haematol; 1998 Jun; 11(2):447-60. PubMed ID: 10097819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].
    Atsushi Y
    Rinsho Ketsueki; 2022; 63(9):1233-1241. PubMed ID: 36198549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia.
    Arora K; Rodgers S; Alkhatib Y; Onwubiko IN; Padmanabhan A; Otrock ZK
    Blood Coagul Fibrinolysis; 2021 Oct; 32(7):522-525. PubMed ID: 34261860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on heparin-induced thrombocytopenia: diagnosis and management.
    Bakchoul T
    Expert Opin Drug Saf; 2016 Jun; 15(6):787-97. PubMed ID: 26966871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of heparin-induced thrombocytopenia.
    Warkentin TE; Greinacher A
    Curr Opin Hematol; 2016 Sep; 23(5):462-70. PubMed ID: 27380556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
    Baldwin ZK; Spitzer AL; Ng VL; Harken AH
    Surgery; 2008 Mar; 143(3):305-12. PubMed ID: 18291250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
    Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Dhakal B; Pierce B; Aster RH; Padmanabhan A
    Chest; 2017 Oct; 152(4):e77-e80. PubMed ID: 28991552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.